Psyched: Numinus, MAPS To Spearhead MDMA Trials; Vancouver Plans To Decriminalize Drugs
Numinus and MAPS Collaborate to Study MDMA in Canada
Numinus Wellness (TSXV: NUMI) and the MAPS Public Benefit Corporation have joined forces to bring MDMA-assisted psychotherapy through clinical trials for approval in Canada.
